期刊
CHINESE MEDICAL JOURNAL
卷 133, 期 24, 页码 2987-2997出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CM9.0000000000001141
关键词
Clinical application; Lung cancer; Mechanism; Traditional Chinese medicine
资金
- National Natural Science Foundation of China [81773904]
- National Key R&D Program of China [2018YFC1707101]
- National Major Scientific and Technological Special Project for Significant New Drugs Development [2018ZX09731001]
- Research Fund Project of Heilongjiang University of Traditional Chinese Medicine [201720]
- Research Fund Project of Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education [2014012]
Lung cancer is a malignant tumor characterized by a rapid proliferation rate, less survivability, high mortality, and metastatic potential. This review focuses on updated research about the clinical application of traditional Chinese medicine (TCM) as an adjuvant therapy to lung cancer treatment and the mechanisms of TCM effect on lung cancer in vitro and in vivo. We summarized the recent 5 years of different research progress on clinical applications and antitumor mechanisms of TCM in the treatment of lung cancer. As a potent adjuvant therapy, TCM could enhance conventional treatments (chemotherapy, radiation therapy, and epidermal growth factor receptors [EGFRs] tyrosine kinase inhibitors [TKIs]) effects as well as provide synergistic effects, enhance chemotherapy drugs chemosensitivity, reverse drug resistance, reduce adverse reactions and toxicity, relieve patients' pain and improve quality of life (QOL). After treating with TCM, lung cancer cells will induce apoptosis and/or autophagy, suppress metastasis, impact immune reaction, and therapeutic effect of EGFR-TKIs. Therefore, TCM is a promisingly potent adjuvant therapy in the treatment of lung cancer and its multiple mechanisms are worthy of an in-depth study.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据